Cubist Systematic Strategies’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-8,746
Closed -$256K 2233
2017
Q3
$256K Buy
8,746
+1,241
+17% +$34.8K 0.01% 1282
2017
Q2
$197K Sell
7,505
-3,804
-34% -$93.5K 0.01% 1293
2017
Q1
$265K Buy
11,309
+1,610
+17% +$39.7K 0.02% 997
2016
Q4
$244K Sell
9,699
-353
-4% -$8.91K 0.02% 1119
2016
Q3
$282K Buy
+10,052
New +$258K 0.02% 1046
2016
Q1
Sell
-9,287
Closed -$325K 1976
2015
Q4
$325K Buy
9,287
+3,257
+54% +$102K 0.02% 1075
2015
Q3
$172K Sell
6,030
-2,121
-26% -$71.3K 0.01% 1516
2015
Q2
$271K Sell
8,151
-231
-3% -$7.09K 0.01% 1277
2015
Q1
$236K Sell
8,382
-36,604
-81% -$910K 0.01% 1420
2014
Q4
$932K Buy
44,986
+32,373
+257% +$768K 0.05% 541
2014
Q3
$308K Buy
+12,613
New +$334K 0.02% 1091

Cubist Systematic Strategies's PMC Position: Q4 2017 in Review

Cubist Systematic Strategies sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 8,746 shares — an estimated $256K sold.

Cubist Systematic Strategies first reported a position in PMC in Q3 2014 and held it in 11 quarters. The position peaked at $932K in Q4 2014. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

  • Cubist Systematic Strategies reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
  • Cubist Systematic Strategies sold 8,746 PharMerica Corporation shares in Q4 2017, an estimated $256K.
  • Cubist Systematic Strategies first reported a position in PharMerica Corporation in Q3 2014 and held it in 11 quarters.
  • Cubist Systematic Strategies's PharMerica Corporation position peaked at $932K in Q4 2014.
  • 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on Cubist Systematic Strategies's 13F filing for Q4 2017, filed 14 Feb 2018.